Current position:Home >Product >
ethyl (4S)-4-(2-methoxyphenyl)-6-[(1-methylimidazol-2-yl)sulfanylmethyl]-2-oxidanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate
ethyl (4S)-4-(2-methoxyphenyl)-6-[(1-methylimidazol-2-yl)sulfanylmethyl]-2-oxidanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate
|
|
Canonical SMILES:
CCOC(=O)C1=C(NC(=O)NC1C2=CC=CC=C2OC)CSC3=NC=CN3C
Isomeric SMILES
CCOC(=O)C1=C(NC(=O)N[C@H]1C2=CC=CC=C2OC)CSC3=NC=CN3C
InChI
InChI=1S/C19H22N4O4S/c1-4-27-17(24)15-13(11-28-19-20-9-10-23(19)2)21-18(25)22-16(15)12-7-5-6-8-14(12)26-3/h5-10,16H,4,11H2,1-3H3,(H2,21,22,25)/t16-/m0/s1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- methyl (4R)-4-(3,4-dimethoxyphenyl)-6-[(1-methylimidazol-2-yl)sulfanylmethyl]-2-oxidanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate
- cyclohexylmethyl (6R)-6-(4-chlorophenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
- [(2R)-oxolan-2-yl]methyl (6S)-6-(4-ethylphenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
- diethyl-[3-[[(3R)-1-(1-ethylbenzimidazol-2-yl)piperidin-3-yl]carbonylamino]propyl]azanium
- (3R)-N-[3-(diethylamino)propyl]-1-(1-ethylbenzimidazol-2-yl)piperidine-3-carboxamide
- methyl (4R)-4-(3-methoxyphenyl)-6-[(1-methylimidazol-2-yl)sulfanylmethyl]-2-oxidanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate
- 2-phenoxyethyl (6R)-6-(4-fluorophenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
- 2-methylsulfanylethyl (6S)-6-(4-ethylphenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
- pentyl (6R)-6-(3,4-dimethoxyphenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
- 2-propan-2-yloxyethyl (6R)-6-(3,4-dimethoxyphenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate

